Is it safe?
Can PTCT take a bad year?
PTC Therapeutics, Inc. holds $1.64B more cash than debt, and is burning $9.9M a quarter, about 56.0 years of cover.
$1.64B
Net cash
- Net debt / EBITDA
- net cash
Net debt / EBITDA · no net borrowings to measure against earnings
- Altman Z-score
- 2.05
Altman Z-score · grey zone, between 1.8 and 3
- Cash runway
- 5+ years
Cash runway · burning $9.9M a quarter at the current rate
Details›
- Total debtQ2 2026
- $591M
- Cash and short-term investments
- $2.23B
- Net cash
- $1.64B
- EBITDA, trailing twelve months
- $173M
- Operating profit, trailing twelve months
- $126M
- Total debt / EBITDA
- 3.41×
- Annualised volatilitytwo years of daily moves
- 50%
- Worst drawdown on file
- −74%
- Below its 52-week high
- −16%
Balance sheet from SEC filings; drawdown and volatility from end-of-day closes; Altman Z from the filed statements.